The Human Monoclonal anti-NKG2D (Tesnatilimab Biosimilar) antibody has been validated for . It is suitable to detect NKG2D (Tesnatilimab Biosimilar) in samples from Human.
Catalog No. ABIN7598035
Quick Overview for Recombinant NKG2D (Tesnatilimab Biosimilar) antibody (ABIN7598035)
Target
NKG2D (Tesnatilimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This NKG2D (Tesnatilimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
Expression System
Mammalian cells
Purpose
Research Grade Tesnatilimab Biosimilar Antibody
Specificity
KLRK1, NKG2D, Killer cell lectin-like receptor subfamily K member 1, NKG2-D-activating NK receptor, D12S2489E, NKG2-D type II integral membrane protein, NK cell receptor D, CD314
Purification
Protein A or G purified from cell culture supernatant.
Reactivity: Human
ELISA, FACS, BLI, Func, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target
NKG2D (Tesnatilimab Biosimilar)
Alternative Name
Tesnatilimab Biosimilar
Target Type
Biosimilar
Background
KLRK1, NKG2D, Killer cell lectin-like receptor subfamily K member 1, NKG2-D-activating NK receptor, D12S2489E, NKG2-D type II integral membrane protein, NK cell receptor D, CD314